Cambium Bio Signs Strategic MoU with Benta SAS
Filed with ASX · · 4 pages · English
Earlier from Cambium Bio
- Cambium Bio Signs US$2.0M plus Licensing Deal
- FY25 Appendix 4E and Annual Report
- Placement Participant Update
- Cambium Bio Raises A$2.12 million
- Half Year Report (December 2024)Cambium Bio Limited Half Year Report (December 2024) (Feb 27, 2025Feb 27, 2025)
Later from Cambium Bio
- Cambium Bio Secures A$2.4 Million Strategic Investment
- Quarterly Activities/Appendix 4C Cash Flow Report
- Half Year Report and Accounts
- FDA Confirms Single Pivotal Trial Pathway for Elate Ocular
- Cambium Bio Raises A$1.0 Million via Placement
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio